Clinical Trial Update: Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for VOY-101 in advanced non-neovascular age-related macular degeneration and geographic atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• VOY-101

Snippet

Sponsor: Perceive Biotherapeutics, Inc. | Conditions: Age-related Macular Degeneration, Geographic Atrophy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING